Key benchmark indices trimmed further gains in mid-morning trade and hit fresh intraday low. At 11:25 IST, the S&P BSE Sensex was up 57.45 points or 0.2% at 28,300.74. The Nifty 50 index was up 19.25 points or 0.22% at 8,757.35. Gains on domestic bourses were supported by positive Asian stocks.
The Sensex rose 159.36 points or 0.56% at the day's high of 28,402.65 in early trade, its highest level since 29 September 2016. The barometer index rose 45.57 points or 0.16% at the day's low of 28,288.86 in mid-morning trade. The Nifty rose 40.20 points or 0.46% at the day's high of 8,778.30 in early trade, its highest level since 29 September 2016. The index rose 10.35 points or 0.12% at the day's low of 8,748.45 in mid-morning trade.
In overseas stock markets, Asian stocks rose after data showing expansion in US manufacturing boosted optimism over the health of the world's largest economy. China's stock exchange remained closed as part of a five-day National Holiday break. US stocks closed lower yesterday, 3 October 2016 as investors digested key economic news and kept an eye on oil prices.
Closer home, the market breadth indicating the overall health of the market was positive. On BSE, 1,436 shares gained and 995 shares fell. A total of 98 shares were unchanged. The BSE Mid-Cap index was up 0.36%. The BSE Small-Cap index was up 0.41%. Both these indices outperformed the Sensex.
Pharma stocks rose. Cipla (up 2.39%), Cadila Healthcare (up 0.5%), Glenmark Pharmaceuticals (up 1.13%), Lupin (up 0.57%), Sun Pharmaceutical Industries (up 1.3%), GlaxoSmithKline Pharmaceuticals (up 0.58%), Aurobindo Pharma (up 1.16%) rose. Dr Reddy's Laboratories (down 0.29%), Alkem Laboratories (down 0.46%) fell.
Wockhardt rose 2.88% after the company said that US drug regulator has excluded Ceftriazone Sodium from import alert. The announcement was made after market hours yesterday, 3 October 2016. Wockhardt announced that US Food and Drug Administration (USFDA) on 30 September 2016 excluded the product Ceftriazone Sodium from import alert 66-40 announced by USFDA on the company's active pharmaceutical ingredients (API) unit at Ankleshwar, Gujarat on 8 August 2016. This will enable the company to manufacture and sell Ceftriazone API and formulation to US market. On 29 September 2016, Wockhardt announced that inspection of the company's manufacturing unit at L-1, Chikalthana, Aurangabad, Maharashtra by UK Medicines and Healthcare products Regulatory Agency (MHRA) has since been completed without any critical observations and the approval status of the said unit continues.
Capital goods stocks saw mixed trend. Punj Lloyd (up 1.3%), Bharat Heavy Electricals (Bhel) (up 0.44%), BEML (up 1.85%), Bharat Electronics (up 0.16%), Thermax (up 1.33%) rose. ABB India (down 0.41%), Crompton Greaves (down 0.76%), Siemens (down 0.25%) fell.
More From This Section
L&T fell 0.88%. The company said it has achieved synchronisation of a power plant unit in Rajasthan in record time. The 2x660 megawatts (MW) supercritical thermal power project at Chhabra in Rajasthan is being executed by L&T. The project had on 2 October 2016 achieved synchronisation of its first 660 MW supercritical unit (unit-5) in record time of 42 months and 4 days from the date of notice to proceed (28 March 2013). The announcement was made during market hours today, 4 October 2016.
Majesco rose 3.86% after the company announced a five-year partnership with IBM to jointly offer a new cognitive, cloud-based platform to help insurance carriers create new services on IBM Cloud. The global partnership between Majesco and IBM is intended to help provide clients with the ability to speed the development of new customer services with predictive data analytics for insurance providers to bring new solutions to their clients. The announcement was made during market hours today, 4 October 2016.
The major event today, 4 October 2016 is the Reserve Bank of India's (RBI) fourth bi-monthly monetary policy meeting. The RBI after the third bi-monthly monetary policy on 9 August 2016, decided to keep the policy repo rate unchanged at 6.5%. Consequently, the reverse repo rate remained unchanged at 6%. RBI also kept the cash reserve ratio (CRR) of scheduled banks unchanged at 4%.
The latest monetary policy meeting will be the first meet where the interest rate decision is taken by a panel. Urjit Patel, the RBI governor, will be one among the six-member Monetary Policy Committee (MPC) recently notified by the government.
Powered by Capital Market - Live News